simendan has been researched along with Chronic Lung Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alkan, M; Arslan, M; Erkent, FD; Kılıç, Y; Kucuk, A; Mardin, B; Oktar, GL; Özer, A; Sezen, ŞC; Tosun, M; Ünal, Y | 1 |
| Alkan, M; Arslan, M; Bilge, M; Çelik, A; Erdem, Ö; Kavutçu, M; Kip, G; Kiraz, HA; Özer, A; Şıvgın, V | 1 |
2 other study(ies) available for simendan and Chronic Lung Injury
| Article | Year |
|---|---|
Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats.
Topics: Animals; bcl-2-Associated X Protein; Benzoquinones; Hydrazones; Immunohistochemistry; Injections, Intraperitoneal; Lung Injury; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Proto-Oncogene Proteins c-bcl-2; Pyridazines; Rats; Rats, Wistar; Simendan | 2018 |
The effect of levosimendan on lung damage after myocardial ischemia reperfusion in rats in which experimental diabetes was induced.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Hydrazones; Lung Injury; Male; Myocardial Reperfusion Injury; Pyridazines; Random Allocation; Rats, Wistar; Simendan; Vasodilator Agents | 2015 |